Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapy

2 years ago 481

Purdue University researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy effects against malignant tumors.

Source: phys.org

Read Entire Article Source

To remove this article - Removal Request